Carlos Rodriguez de Lope1

Hepatology · 2010

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Carlos Rodriguez de Lope1 trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Llovet

Papers from Carlos Rodriguez de Lope1's perspective

Ordered by how strongly the researchers Carlos Rodriguez de Lope1 trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Molecular Targeted Therapies in Hepatocellular Carcinoma (Hepatology)
  2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
  3. Diagnosis and treatment of hepatocellular carcinoma. (Gastroenterology)
  4. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. (Gastroenterology)
  5. A System of Classifying Microvascular Invasion to Predict Outcome after Resection in Patients with Hepatocellular Carcinoma (Gastroenterology)
  6. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival (Hepatology)
  7. Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma (Cancer Research)
  8. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. (Cancer Research)
  9. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. (Radiology)
  10. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. (Gastroenterology)

Their papers